Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanna Naudé

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Gynecologic Oncology|December 26, 2001
Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with high mitotic activity and high FIGO stageHermann Brustmann, Susanna Naudé
Gynecologic Oncology|July 30, 2002
Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesionsHermann Brustmann, Susanna Naudé
Pathology, Research and Practice|June 19, 2003
Galectin-3 expression in normal, hyperplastic, and neoplastic endometrial tissuesHermann Brustmann, Dominik Riss, Susanna Naudé
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Gynecologic Oncology|December 26, 2001
Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with high mitotic activity and high FIGO stageHermann Brustmann, Susanna Naudé
Gynecologic Oncology|July 30, 2002
Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesionsHermann Brustmann, Susanna Naudé
Pathology, Research and Practice|June 19, 2003
Galectin-3 expression in normal, hyperplastic, and neoplastic endometrial tissuesHermann Brustmann, Dominik Riss, Susanna Naudé
Pageof 1